Market revenue in 2023 | USD 548.8 million |
Market revenue in 2030 | USD 1,301.0 million |
Growth rate | 13.1% (CAGR from 2023 to 2030) |
Largest segment | Chromatography systems |
Fastest growing segment | Filters |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Chromatography Systems, Filters, Evaporators, Centrifuges, Dryers |
Key market players worldwide | Merck KGaA, Sartorius AG, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Danaher Corp, Repligen Corp, 3M Co, Boehringer Ingelheim, Corning Inc, Lonza Group Ltd, Dover Corp, Asahi Kasei Corp, Eppendorf |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to downstream processing market will help companies and investors design strategic landscapes.
Chromatography systems was the largest segment with a revenue share of 38.48% in 2023. Horizon Databook has segmented the Brazil downstream processing market based on chromatography systems, filters, evaporators, centrifuges, dryers covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is considered a small-molecule pharmaceutical market. Some of the biggest local manufacturers in Brazil include small molecule generics companies. However, in recent years, the country acknowledged the importance of establishing a biotechnology industry. The Brazilian downstream processing market is majorly driven by growing demand for vaccines, antibodies, and other biosimilars within the country.
Vaccines are important for the control of infectious diseases. Government institutions associated with the Ministry of Health majorly support the R&D and production of immunobiologicals in Brazil, especially vaccines used for humans. This helps in prioritizing the public sector for access to vaccines and other biologicals that are considered essential for the population. The country has increased its focus for improving production so that they do not depend on imports for major vaccines for public health and also strengthen the Brazilian biotechnology-related industrial sector.
Moreover, rise in adoption of biosimilars would further drive the market. For instance, Biosimilar Trastuzumab was approved for use by ANVISA, the Brazilian regulatory agency, in 2017. The drug is the first approved biosimilar of Trastuzumab in the country and is indicated for use in breast and gastric cancers.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil downstream processing market , including forecasts for subscribers. This country databook contains high-level insights into Brazil downstream processing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account